Abu MN, Samat S, Kamarapani N, Hussein FN, Ismail WIW Hassan HF (2015). Tinospora crispa Ameliorates insulin resistance induced by high fat diet in wistar rats. Evid-Based Complement. Altern. Med. 2015:6.

Andrés-Blasco I, Herrero-Cervera A, Vinué Á, Martínez-Hervás S, Piqueras L, Sanz MJ, Burks DJ, González-Navarro H (2015). Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis. J. Endocrinol. 227(3):179-191.
Crossref

Atshaves BP, McIntosh AL, Martin GG, Landrock D, Payne HR, Bhuvanendran S, Landrock K, Lyuksyutova OI, Johnson JD, Macfarlane RD, Kier AB, Schroeder F (2009). Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice. J. Lipid Res. 50:1429-1447.
Crossref

Bergstrom JD, Bostedor RG, Rew DJ, Geissler WM, Wright SD, Chao YS (1998). Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin. Biochim. Biophys. Acta 1389:213-221.
Crossref

Brown RJ, Lagor WR, Sankaranaravanan S, Yasuda T, Quertermous T, Rothblat GH, Rader DJ (2010). Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Circ. Res. 107(3):357-364.
Crossref

Carneiro MM, Miname MH, Gagliardi AC, Pereira C, Pereira AC, Krieger JE, Maranhão RC, Santos RD (2012). The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions. Atherosclerosis 221(1):268-274.
Crossref

Chemat F, Vian MA, Cravotto G (2012). Green extraction of natural products: concept and principles. Int. J. Mol. Sci. 13:8615-8627.
Crossref

Dashti N (1992). The effects of low density lipoproreins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J. Biol. Chem. 267:7160-7169.

Friedman RC, Farh KKH, Burge CB, Bartel DP (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92-105.
Crossref

Funatsu T, Suzuki K, Goto M, Arai Y, Kakuta H, Tanaka H, Yasuda S, Ida M, Nishijima S, Miyata K (2001). Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells. Atherosclerosis 157(1):107-115.
Crossref

Getz GS, Reardon CA (2011). Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis. J. Inflamm. Res. 4:83-92.
Crossref

Ghanya AN, Maznah I, Gururaj B, Hadiza AA (2010). Vanillin rich fraction regulates LDLR and HMGCR gene expression in HepG2 cells. Food Res. Int. 43(10):2437-2443.
Crossref

Ghosh S (2012). Early steps in reverse cholesterol transport: cholesteryl ester hydrolase and other hydrolases. Curr. Opin. Endocrinol. Diabetes Obes. 19(2):136-141.
Crossref

Gillard BK, ll Bassett G, Gotto Jr AM, Rosales C and Pownall HJ (2017). Scavenger Receptor B1 (SR-B1) Profoundly Excludes High Density Lipoprotein (HDL) Apolipoprotein AII as it Nibbles HDL-Cholesteryl Ester. J. Biol. Chem. 292(21):8864-8873.
Crossref

Hasan MKN, Kamarazaman IS, Arapoc DJ, Taza NZM, Amom ZH, Ali RM, Arshad MSM, Shah ZM, Kadir KKA (2015). Anticholesterol Activity of Anacardium occidentale Linn. Does it involve in Reverse Cholesterol Transport? Sains Malaysiana 44(10):1501-1510.
Crossref

Hiromitsu Y, Yoshiaki H, Shigeo O, Masato Y, Fumiko M, Mitsunobu K, Kazuo K, Yasuteru U, Sachiyo S, Kiyoshi K, Kazuhiko N (2002), Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD. Atherosclerosis 162(2):399-407.
Crossref

Hubert S, Renana S, Hedi G, Markus N, Heinrich W, Winfried M (2001). Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in Hep G2 cells. Biochem. Pharmacol. 62:1545-1555.
Crossref

Hwang KA, Hwang YJ, Song J (2017). Cholesterol-lowering effect of Aralia elata (Miq.) Seem via the activation of SREBP-2 and the LDL receptor. J. Chin. Med. Assoc. 80(10):630-635.
Crossref

Kamarazaman IS, Amom Z, Ali RM (2012). Inhibitory properties of Tinospora crispa extracts on TNF-α induced inflammation on human umbilical vein endothelial cells (HUVECS). Int. J. Trop. Med. 7:24-29.
Crossref9

Kishor S, Jain MK, Kathiravan, Rahul S, Somani, Chamanlal J, Shishoo (2007). The biology and chemistry of hyperlipidemia. Bioorg. Med. Chem. 15:4674-4699.
Crossref

Kuivenhoven JA, Pritchard H: Hill J, Frohlich J, Assmann G, Kasteleinet J (1997). The molecular pathology of lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38:191-205.

Kumar V, Mahdi F, Chander R, Husain I, Kumar AK, Singh R, Saxena JK, Mahdi AA and Singh4 RK (2013). Tinospora cordifolia regulates lipid metabolism in allaxon induced diabetes in rats. Int. J. Pharm. Life Sci. 4(10):3010-3017.

Meisel P, Kohlmann T, Wallaschofski H, Kroemer HK, Kocher T (2011). Cholesterol, C - reactive protein and periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers. ISRN Dent. 2011:125168.
Crossref

Milada D, Jiri JF (1999). Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport. Clin. Chim. Acta 286(1-2):257-271.
Crossref

Md HA, Islam ASM, Mohammad S (2011). Antimicrobial, Cytotoxicity and Antioxidant Activity of Tinospora crispa. J. Pharm. Biomed. Sci. 13(12):1-4.

Nagaraja PK, Kammar KF, Sheela DR (2008). Efficacy of Tinospora cordifolia (Willd.) extracts on blood lipid profile in streptozotocin diabetic rats. Is it beneficial to the heart? Biomed. Res. 19(2):92-96.

Ohashi R, Mu H, Wang X, Yao Q, Chen C (2005). Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Q. J. Med. 98:845-856.
Crossref

Paul N, Leon S, Phillip B, Peter C, David C, Ian HC, Ken S, David S (1997). A comparative study of the efficacy of AOE and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein (a) and insulin. Atherosclerosis 129(2):231-239.
Crossref

Peter JM, Barbara L, Hubert S, Stephen K, Karin B (2010). Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and Hep G2 cells, and consequences for statin-induced myopathy. Biochem. Pharmacol. 79:1200-1209.
Crossref

Petras SF, Lindsey S, Harwood JHJ (1999). HMG-CoA reductase regulation: Use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells. J. Lipid Res. 40:24-38.

Pingale SP (2011). Acute toxicity study for Tinospora cordifolia. Int. J. Res. Ayur. Phar. 2(5):1571-1573.

Polisecki E, Muallem H, Maeda N, Peter I, Robertson M, McMahon AD, Ford I, Packard C, Shepherd J, Jukema JW, Westendorp RG, de Craen AJ, Buckley BM, Ordovas JM, Schaefer EJ (2008). Prospective study of pravastatin in the elderly at risk (PROSPER) investigators. Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER. Atherosclerosis 200(1):109-114.
Crossref

Pruthu K (2014). Organic solvents - health hazards. National Seminar on Impact of Toxic Metals, Minerals and Solvents leading to Environmental Pollution. J. Chem. Pharm. Sci. 3:83-86.

Sander JR, Joan MF, Raymond L, George MP (1989). The transport of lipoprotein cholesterol into bile: a reassessment of kinetic studies in the experimental animal. Biochim Biophys Acta. 1004(3):327-331.
Crossref

Scharnagl H, Schinker R, Gierens H, Nauck M, Wieland H, Ma¨rz W (2001). Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. Biochem. Pharmacol. 62:1545-1555.
Crossref

Talubmook C, Buddhakala N (2013). Bioactivities of etracts from Tinospora crispa stems, Annona squamosa leaves, Musa sapientum flowers, and Piper sarmentosum leaves in diabetic rats. Int. J. Adv. Res. Technol. 2(6):144-149.

Tungpradit R, Sinchaikul S, Phutrakul S,Wongkham W and Chen ST (2010). Anti-cancer compound screening and isolation:Coscinium fenestratum, Tinospora crispa and Tinospora cordifolia. Chiang Mai J. Sci. 37(3):476-488.

Van der Velde AE, Brufau G, Groen AK (2010). Transintestinal cholesterol efflux. Curr. Opin. Lipidol. 21(3):167-71.
Crossref

Van Eck M, Twisk J, Hoekstra M, Van Rij BT, Van der Lans CAC, I. Bos ST, Kruijt JK, Kuipers F and Van Berkel TJC (2003). Differential Effects of Scavenger Receptor BI Deficiency on Lipid Metabolism in Cells of the Arterial Wall and in the Liver. J. Biol. Chem. 278(26):23699-23705.
Crossref

Wilcox LJ, Barrett PHR, Huff MW (1999). Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin. J. Lipid Res. 40:1078-1089.

Yanagita T, Yamamoto, K, Ishida, S, Sonda K, Morito F, Saku K, Sakai T (1994). Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells. Clin. Ther. 16:200-208.

Yokoyama M, Seo T, Park T, Yagyu H, Hu Y, Son NH, Augustus AS, Vikramadithyan RK, Ramakrishnan R, Pulawa LK, Eckel RH, Goldberg IJ (2007). Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle. J. Lipid Res. 48(3):646-655.
Crossref

Zannis VI, Chroni A, Krieger M (2006). Role of apoA-I, ABCA1, LCAT and SR-BI in the biogenesis of HDL. J. Mol. Med. (Berl). 84(4):276-294.
Crossref

Zulkhairi A, Abdah MA, Kamal NH (2008). Biological Properties of Tinospora crispa (Akar Patawali) and Its antiproliferative activities on selected human cancer cell lines. Malay. J. Nutr. 14:173-187.

Zulkhairi A, Hasnah B, Zamree MS, Shahidan MA, Nursakinah I, Fauziah O, Maznah I, Taufik Hidayat M, Moklas and Khairul Kamilah AK (2009). Potential of Tinospora crispa as a hypocholesterolemic agent in rabbit. Malay. J. Med. Health Sci. 5(2):1-10.